Work

Targeting B cells in severe thrombotic thrombocytopenic purpura–a road to cure?*

Year: 2011

Type: editorial

Abstract: Division of Rheumatology Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA * See also p. 104. Dr. Kyttaris has received funding from the National Institutes of Health.

Source: Critical Care Medicine

DOI: 10.1097/ccm.0b013e318232d2b6

Author: Vasileios C. Kyttaris

Institutions: Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: Complement system in diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: G13319477, NFAT/AP-1 cooperation in SLE T cells, The Role of Interleukin 23 in Lupus

OpenAlex ID: W2058798449

Cites: 3

Cited by: 3

Related to: 10